07:00 , Jul 19, 2012 |  BC Innovations  |  Targets & Mechanisms

OutFOXing tumors

A Mount Sinai School of Medicine and Case Western Reserve University team has found a new use for the dopamine receptor antagonist trifluoperazine: restoring the sensitivity of tumors to epidermal growth factor receptor inhibitors. 1...
07:00 , Aug 5, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers A six-gene signature involving Krupple-like factor 6 (KLF6; COPEB; ZF9), FBJ murine osteosarcoma viral oncogene homolog B (FOSB), nuclear factor of k light polypeptide gene enhancer...
08:00 , Dec 24, 2001 |  BC Week In Review  |  Company News

Mount Sinai School of Medicine other research news

Researchers published in Science analysis of 22 primary prostate tumor samples showing that 1 KLF6 gene was deleted in 77% (17/22) of the tumors. In addition, sequencing of the retained KLF6 allele showed mutations in...